medicinal product

Also found in: Wikipedia.

medicinal product

A term which is defined by the UK’s Nursing and Midwifery Council Directive 65/65/EEC as: “Any substance or combination of substances presented for treating or preventing disease in human beings or in animals. Any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in human beings or animals is likewise considered a medicinal product.”

medicinal product,

n a substance administered to humans or animals through injection, application, oral ingestion, inhalation, and so forth, whose purpose is to ultimately restore health or eliminate disease in an individual.

Patient discussion about medicinal product

Q. is it ok to use drugs for medical reasons? and who is to decide when is necessary to use drugs when needed?

A. Today the most used "medical" drugs are narcotics- for pain relief, for patients who suffer extreme pain. All sorts of Codaine and Morphine types are used and on a very wide basis, and they are specially perscribed for ones who need them.

Q. How about Psychiatric Drugs for bipolar? One of my friend is suffering from bipolar. Will Psychiatric medications help him to come out of this affect?

A. from what i read- there are certain medication that can help. if the first one doesn't - there is a second and third line of medication. from a personal experience (not mine, a friend of the family) it can even save your friend's life..

Q. What medications are forbidden to take with alcohol? And why is that?

A. I think this web page will give you something to think about:
apparently there are more drugs you shouldn’t mix with alcohol then I could think of…

More discussions about medicinal product
References in periodicals archive ?
Regarding therapeutic indications for herbal medicinal products with a well-established medicinal use, a standard statement "herbal medicinal product .
Arimoclomol has also been granted orphan medicinal product status for the treatment of ALS by the European Commission.
4 * should be used to treat cancer that circumstance specified in the authorization for the medicinal product.
The Company controls/owns exclusive worldwide ownership/rights for a total of 134 proprietary natural herbal medicinal products/formulas as Two Natural Herbal Medicinal Product lines: King of Herbs products and Taoist Medicinal products.
The contractor is obliged to deliver the medicinal product from the label, the label in the language of Polish (if applicable).
3) was revised in order to include a reference to the "Guideline on excipients in the label and package leaflet of medicinal products for human use" and to the need to put an appropriate warning on the label in case a herbal medicinal product contains alcohol.
LOS ANGELES -- CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that its lead drug candidate arimoclomol has been granted orphan medicinal product status for the treatment of amyotrophic lateral sclerosis (ALS) by the European Commission.
This Directive will amend the existing European Directive 2001/83/EC which provides the basic requirements for marketing authorization of a medicinal product including the proof of quality, safety and efficacy.
In addition to the general provisions on labelling and content of package leaflets, a specific statement will be included that the product is a traditional herbal medicinal product and that its efficacy has not been clinically proven but relies on tradition.
Nektar Therapeutics (Nasdaq:NKTR) announced today that its Amphotericin B Inhalation Powder (ABIP) product has been granted orphan medicinal product designation by the European Commission for the prevention of pulmonary fungal infections in patients deemed at risk.
XOMA Ltd (Nasdaq:XOMA) announced today that the European Commission has granted an orphan medicinal product designation to XOMA's drug NEUPREX(R) (opebacan) in meningococcal disease, a potentially life-threatening bacterial infection predominantly affecting young children.
On July 14, 2006, the EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion that opebacan (NEUPREX(R)) be granted Orphan Medicinal Product designation in meningococcal disease.